Baudax Bio Inc reports results for the quarter ended in March - Earnings Summary

Baudax Bio

12/05/2023 14:18

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted
loss of
$3.91​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for earnings of $5.75 per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Baudax Bio Inc's reported EPS for the quarter was $4.91​.
    * The mean earnings estimate of analysts had risen by
about 423%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Baudax Bio Inc shares had fallen by 60.0% this quarter and
lost 78.6% so far this year.
    * The company reported quarterly net income of $11.4
million.
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$24.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 01:18 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      5.75           -3.91          Missed
 Dec. 31 2022      -9.76          -12.33         Missed
 Sep. 30 2022      -21.20         -26.40         Missed
 Jun. 30 2022      -50.80         -42.00         Beat